Kateryna Bertuch, MD | |
538 Litchfield St, Torrington, CT 06790-6669 | |
(860) 496-1790 | |
Not Available |
Full Name | Kateryna Bertuch |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 17 Years |
Location | 538 Litchfield St, Torrington, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811239817 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 61887 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hartford Hospital | Hartford, CT | Hospital |
Charlotte Hungerford Hospital | Torrington, CT | Hospital |
Sharon Hospital | Sharon, CT | Hospital |
The Hospital Of Central Connecticut | New britain, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has received a new patent in the United States.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed its Phase I study with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.
A new study, recently released as a preprint on the medRxiv* server, reports the intriguing finding that the cross-neutralizing antibodies elicited by human seasonal coronaviruses (sCoVs) show varying ability to prevent binding between the SARS-CoV-2 spike antigen and its cognate receptor, the angiotensin-converting enzyme 2 (ACE2).
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
Food scientists at the National University of Singapore have given okara - the residue from the production of soy milk and tofu, and is usually discarded - a new lease of life by turning it into a refreshing drink that contains live probiotics, dietary fiber, free isoflavones and amino acids.
› Verified 7 days ago
Entity Name | Hartford Healthcare Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043561301 PECOS PAC ID: 1153573902 Enrollment ID: O20121201000007 |
News Archive
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has received a new patent in the United States.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed its Phase I study with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.
A new study, recently released as a preprint on the medRxiv* server, reports the intriguing finding that the cross-neutralizing antibodies elicited by human seasonal coronaviruses (sCoVs) show varying ability to prevent binding between the SARS-CoV-2 spike antigen and its cognate receptor, the angiotensin-converting enzyme 2 (ACE2).
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
Food scientists at the National University of Singapore have given okara - the residue from the production of soy milk and tofu, and is usually discarded - a new lease of life by turning it into a refreshing drink that contains live probiotics, dietary fiber, free isoflavones and amino acids.
› Verified 7 days ago
Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has received a new patent in the United States.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed its Phase I study with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.
A new study, recently released as a preprint on the medRxiv* server, reports the intriguing finding that the cross-neutralizing antibodies elicited by human seasonal coronaviruses (sCoVs) show varying ability to prevent binding between the SARS-CoV-2 spike antigen and its cognate receptor, the angiotensin-converting enzyme 2 (ACE2).
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
Food scientists at the National University of Singapore have given okara - the residue from the production of soy milk and tofu, and is usually discarded - a new lease of life by turning it into a refreshing drink that contains live probiotics, dietary fiber, free isoflavones and amino acids.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Kateryna Bertuch, MD 538 Litchfield St, Torrington, CT 06790-6669 Ph: (860) 496-1790 | Kateryna Bertuch, MD 538 Litchfield St, Torrington, CT 06790-6669 Ph: (860) 496-1790 |
News Archive
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has received a new patent in the United States.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed its Phase I study with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.
A new study, recently released as a preprint on the medRxiv* server, reports the intriguing finding that the cross-neutralizing antibodies elicited by human seasonal coronaviruses (sCoVs) show varying ability to prevent binding between the SARS-CoV-2 spike antigen and its cognate receptor, the angiotensin-converting enzyme 2 (ACE2).
A recent paper by researchers from the Netherlands and Poland provides evidence that modified ebselen derivatives may serve as highly promising prospective drugs against coronavirus disease 2019 (COVID-19). The manuscript is freely available on the bioRxiv* preprint server.
Food scientists at the National University of Singapore have given okara - the residue from the production of soy milk and tofu, and is usually discarded - a new lease of life by turning it into a refreshing drink that contains live probiotics, dietary fiber, free isoflavones and amino acids.
› Verified 7 days ago
Joseph E Abreu, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1215 New Litchfield Street, Torrington, CT 06790 Phone: 860-489-1132 Fax: 860-489-0434 | |
Dr. Waile Ramadan, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 52 Peck Rd, Torrington, CT 06790 Phone: 860-489-6899 | |
Michael T Kovalchik, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 780 Litchfield St, Suite200, Torrington, CT 06790 Phone: 860-489-1984 Fax: 860-496-2195 | |
Nicholas Paul Bodmer, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 540 Litchfield St, Torrington, CT 06790 Phone: 860-496-6666 Fax: 860-496-6633 | |
Dr. Michael Corey Magnifico, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 200 Kennedy Dr, Torrington, CT 06790 Phone: 860-482-5384 Fax: 860-496-4951 | |
Albert H Langou, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 540 Litchfield St, Torrington, CT 06790 Phone: 860-496-6557 Fax: 860-496-6718 | |
Kaushal B Shah, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 540 Litchfield St, Torrington, CT 06790 Phone: 732-213-0121 |